Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.
Filings · News reference
Boston Scientific Discloses Its Unlikely To Meet Its FY26 And Q3 Adj EPS And Net Sales Growth Guidance After Cybersecurity Incident
Based on the information currently available as of the date of this Current Report on Form 8-K, the Company has determined that the incident is likely to have a material impact on the Company’s results of operations for
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Boston Scientific shares are trading lower after the company disclosed that it's unlikely to meet its FY26 and Q3 adjusted EPS and net sales growth guidance following a previously announced cybersecurity incident that affected operations.
8-K filing — BOSTON SCIENTIFIC CORP (BSX)
Filed: 2026-09-08 AccNo: 0000885725-26-000059 Size: 192 KB Item 1.05: Material Cybersecurity Incidents